Fennec Pharmaceuticals Inc. announced that Adrian Haigh has departed from his position as Fennec?s chief operating officer as of June 30, 2024. After nine years as an independent director, in August 2023, Adrian joined the Fennec leadership team as chief operating officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.54 USD | +2.35% |
|
+12.56% | -41.71% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.71% | 179M | |
+20.63% | 127B | |
+23.21% | 117B | |
+25.53% | 27.67B | |
-20.17% | 20.33B | |
-16.66% | 16.79B | |
-18.07% | 15.63B | |
+11.92% | 14.84B | |
-47.70% | 14.65B | |
+58.32% | 14.43B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Inc. Announces Executive Changes